TOP SELLING BIOLOGICS MARKET – GAINING TRACTION IN THE PHARMACEUTICAL INDUSTRY AND THE GROWING FUTUR

Less than half a century ago, the pharmaceutical market was dominated by small molecule drugs. However, owing to concerns, such as off target toxicity and low specificity, associated with chemical moieties, and the need to shift from the one-size-fits-all approach to personalized medicine, a better class of pharmacological interventions was required. The first biologic drug, humanized insulin, was approved in 1982; over time, this class of target specific therapeutics have revolutionized the healthcare industry. Briefly, biologics offer several benefits, including target specificity, better therapeutic efficacy and, consequently, favorable safety profiles compared to conventional chemical-based drugs. Moreover, these molecules have also demonstrated the ability to access elusive biological targets and treat diseases that were previously considered undruggable.
To request for Sample report – https://www.rootsanalysis.com/reports/top-selling-biologics-market/request-sample.html

Leave a Reply

Your email address will not be published. Required fields are marked *